Comprehensive reagents from HYPHEN BioMed for the diagnosis and treatment monitoring of hemophilia A, hemophilia B (Christmas disease), von Willebrand disease (vWD), and other congenital bleeding disorders.
BIOPHEN™ FVIII:C chromogenic assays use human FIX/FX reagents validated for emicizumab (Hemlibra®) activity measurement — essential for hemophilia A treatment monitoring in the bispecific antibody era.
BIOPHEN™ FIX chromogenic assays cover standard and extended half-life FIX products.
vWF testing covers antigen (LIAPHEN™, ZYMUTEST™), collagen binding activity (vWF:CBA), and ristocetin cofactor (vWF:RCo) for full von Willebrand disease diagnosis and subtyping. Factor VIII inhibitor plasmas (mild, moderate, severe) support Bethesda and Nijmegen-modified Bethesda assay validation.
| Reference | Product Name | Price | ||
|
|
A226301-RUO
|
BIOPHEN™ FVIIa Calibrator — Activated Factor VII Calibration Set | $346.00 | |
|
|
A224901-RUO-MIN
|
BIOPHEN™ FVIIa Control Set — Activated FVII Quality Control | $255.00 | |
|
|
A221812
|
BIOPHEN™ FIXa — Activated Factor IX Activity Assay | $260.00 | |
|
|
A220412
|
BIOPHEN™ Factor XIa — Activated FXI Activity Chromogenic Assay | $593.00 | |
|
|
A224601-MIN
|
BIOPHEN™ FIXa Control Set — Activated FIX Quality Control | $265.00 | |
|
|
A224801
|
BIOPHEN™ FXIa Control Set — Activated FXI Quality Control | $346.00 | |
|
|
A221801-RUO
|
BIOPHEN™ Factor IX Chromogenic Assay (2 × 1 mL) | $411.00 | |
|
|
A221801-CAN
|
BIOPHEN™ Factor IX Chromogenic Assay (2 × 1 mL) | $394.00 | |
|
|
AAG004K-CAN
|
Ristocetin Platelet Aggregation Reagent — RIPA / vWF:RCo (3 × 7.5 mg) | $289.00 | |
|
|
ADP050K-CAN
|
Factor IX Deficient Plasma (6 × 1 mL) — <1% Residual | $368.00 |